Press Release
Press Release
Exelixis Announces First Quarter 2001 Financial Results Conference Call on the Web
Exelixis, Inc. (Nasdaq: EXEL) today announced that its financial results for the first quarter 2001 will be issued in a press release after the close of the U.S. financial markets on Monday, May 14, 2001 at 4:00 EST. Exelixis will host a conference call one hour after the release at 5:00 EST to discuss these results. The call will be led by George A. Scangos, Ph.D., president and chief executive officer and Glen Y. Sato, chief financial officer and vice president of legal affairs.
To access the conference call over the web, please log on to http://www.exelixis.com/ir or http://www.streetevents.com. If you are unable to participate in the live webcast, the call will be archived until May 24, 2001.
Note: Minimum Requirements to listen to broadcast: RealPlayer software, downloadable free from www.real.com/products/player/index.html, and at least a 14.4Kbps connection to the Internet.
Exelixis, Inc. is a leading life sciences biotechnology company focused on product development through its expertise in comparative genomics and model system genetics. These technologies provide a rapid, efficient and cost effective way to move from DNA sequence data to knowledge about the function of genes and the proteins they encode. The company's technology is broadly applicable to all life sciences industries including pharmaceutical, diagnostic, agricultural biotechnology and animal health. Exelixis has partnerships with Aventis, Bayer, Pharmacia, Bristol-Myers Squibb and Dow AgroSciences and is building its internal development program in the area of oncology. For more information, please visit the company's web site at www.exelixis.com. Exelixis and the Exelixis logo are registered U.S. trademarks. |